fosnetupitant 235 MG / palonosetron 0.25 MG Injection [Akynzeo]
RxNorm concept 2044431, branded drug (sbd). Prescribable name: Akynzeo 235 MG / 0.25 MG Injection.
- RxCUI
- 2044431
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2044431 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Akynzeo (fosnetupitant 235 MG / palonosetron 0.25 MG) Injection
Related concepts
- fosnetupitant 235 MG (SCDC, consists of)
- palonosetron 0.25 MG (SCDC, consists of)
- fosnetupitant 235 MG / palonosetron 0.25 MG [Akynzeo] (SBDC, consists of)
- Injection (DF, has dose form)
- Akynzeo (BN, has ingredient)
- fosnetupitant 235 MG / palonosetron 0.25 MG Injection (SCD, tradename of)
Linked data
NDCs
- 69639010201
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2044431 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2044431 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2044431. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.